Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

CBS-ASC would like to invite you to the first webinar of 2022 that will be held on Thursday, March 3rd, 2022, at 4 pm MST via ZOOM on the topic titled Diversify your career options outside of academia ...

The Canadian Biomaterials Society CBS will be hosting the 37th Annual Meeting in Banff, Alberta in a hybrid format from Wed...

We would like to obtain feedback from our members regarding possible new logo designs. Please vote for your preferred option through the CBS Logo Poll at this location https biomaterials...

The Ottawa Student Chapter is pleased to present The 2022 Biomaterials Challenge We challenge graduate and undergraduate students in Ontario to compete on explaining How to select a biomaterial? and What is biocompatibility? to 7th-grade students in a 3-minute recorded video or an infographic Deadline to submit March 10th, 2022

Glioblastoma comprises more than 50 of all gliomas which is the most frequent type of brain tumor. 1 Current treatment strategies for this cancer includes surgical resection, radiotherapy, and chemotherapy...

Over the last decade, gene therapy has gained increasing attention in the fields of bone regeneration and tissue engineering 1 ...

It is currently established that two-dimensional 2D cancer cell culture fails to recapitulate the essential features of in vivo tumor growth...

Protein adsorption is an initial response to biomaterials and a precursor to thrombus formation and inflammation, which can result in significant challenges to device efficacy...

Continuous subcutaneous insulin infusion CSII is a treatment strategy for Type I diabetes mellitus T1D that relies on insulin infusion sets IIS to deliver insulin to the subcutaneous tissue via a polytetrafluoroethylene PTFE or stainless-steel cannula...